[ACCESSWIRE]
LONDON, UK / ACCESSWIRE / July 6, 2016 / Active Wall St. announces its coverage of market signals with highlight on these Top Gainers from Tuesday's session: Leading Brands, Inc. (NASDAQ: LBIX), Himax Technologies, Inc. (NASDAQ: HIMX), and Insys Therapeutics, Inc. (NASDAQ: INSY). Register with us now for your free membership and get more on our signal alerts at:
http://www.activewallst.com/register/
Stock Market Performance
On Tuesday, July 5, 2016 U.S indexes snapped a four-session rally concerns related the Brexit - to spook the market. Signs of slowing growth in Europe and comments from Bank of England Governor, Mark Carney, also added to the anxiety over the global economic outlook.
The S&P 500 index lost 14.40 points, or 0.68%, to close at 2,088.55, bouncing back from its intraday low of 2,080.
The Dow Jones Industrial Average declined 108.75 points, or 0.61%, to end at 17,840.62, recovering from its intraday low of 17,785.
The Nasdaq Composite dropped 39.67 points, or 0.82%, to close at 4,822.90, after dropping as low as 4,797.
Today, AWS is promoting its market signals coverage with emphasis on LBIX, HIMX, and INSY. Get all of our reports for free by signing up to http://www.activewallst.com/register/.
Active Wall St. takes a look at some of the stocks which managed to eke out gains in yesterday's dropping market.
Top Gainers - Leading Brands
On Tuesday, shares of Leading Brands, Inc. surged 19.53% to close at $2.02. The Company's shares surged after the announcement of results of its Annual General Meeting, which was conducted on June 22, 2016.
The company reported that all resolutions presented in the Annual Meeting passed by a wide margin and that Ralph McRae and Darryl Eddy were re-elected as directors of the Company. Leading Brands also announced plans to supply HappyWater®, in both 500ml bottles and its proprietary WaterBox™, to a China-based customer, with the first shipment expected to be released in Q3FY16.
At the close yesterday, the stock recorded trading volume of 2.06 million shares, higher than its three months average volume of 143,350 shares. Leading Brands' shares have gained 32.03% in the past one month. Get more from this stock at:
http://www.activewallst.com/registration-3/?symbol=LBIX
Top Gainers - Himax Technologies
Shares of Himax Technologies, Inc. gained 7.22% to close at $8.02 on Tuesday after the company announced the release of its preliminary Q2 FY16 financial results.
The semiconductor firm said that it hit the high end of its guidance for revenue and gross margin, while earnings per share were above Himax Technologies' previous guidance. In particular, GAAP earnings of $0.115 per share topped the higher end of the company's predictions by $0.01 per share. Himax Technologies remains positive about its outlook for the remainder of the calendar year. Himax Technologies also explained that the departure of retiring Chief Technology Officer, Chih-Chung Tsai, should have no impact on its technology development because of the interaction of founder Biing-Seng Wu with the rest of the company.
At the close yesterday, a total of 7.02 million of shares changed hands during the session, significantly higher than the three month average volume of 3.32 million shares. The company's stock is up 3.22% for the past 12 months. Sign up now, and access notes on HIMX at:
http://www.activewallst.com/registration-3/?symbol=HIMX
Top Gainers - Insys Therapeutics
On Tuesday, shares of Insys Therapeutics, Inc. climbed 6.90% to finish the trading session at $14.40. Insys Therapeutics gained after company announced that it has won a key approval from the U.S. Food and Drug Administration for Syndros, an orally administered liquid formulation of the pharmaceutical cannabinoid dronabinol, a pharmaceutical version of tetrahydrocannabinol.
Syndros is now allowed for use in treating anorexia associated with weight loss in patients with AIDS, as well as in treating nausea and vomiting from cancer-related chemotherapy treatments in patients who have not responded to conventional treatments. The approval allows the drug to be used orally, making it the only product on the market that can make that claim.
Yesterday, a total of 7.51 million share changed hands as compared to the three month average volume of 659,900 shares. The company's stock has been on a downward trend and has lost 8.69% in the last one month.
Active Wall Street:
Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
AWS has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@activewallst.com
Phone number: 1-858-257-3144
Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: Active Wall Street